| 1 |
35411237 | KMT2D loss drives aggressive tumor phenotypes in cutaneous squamous cell carcinoma. | 2022 |
1 |
| 2 |
34156443 | The MLL3/4 H3K4 methyltransferase complex in establishing an active enhancer landscape. | 2021 Jun 30 |
3 |
| 3 |
34705580 | Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer. | 2021 Jan-Dec |
2 |
| 4 |
34724040 | KMT2D deficiency disturbs the proliferation and cell cycle activity of dental epithelial cell line (LS8) partially via Wnt signaling. | 2021 Nov 26 |
1 |
| 5 |
34859145 | KMT2D deficiency confers a therapeutic vulnerability to glycolytic and IGFR inhibitors in melanoma. | 2021 |
1 |
| 6 |
31935506 | Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders. | 2020 Mar 20 |
1 |
| 7 |
32139118 | MLL2 regulates glucocorticoid receptor-mediated transcription of ENACĪ± in human retinal pigment epithelial cells. | 2020 May 7 |
4 |
| 8 |
32668765 | Loss of Function of the Gene Encoding the Histone Methyltransferase KMT2D Leads to Deregulation of Mitochondrial Respiration. | 2020 Jul 13 |
1 |
| 9 |
32817139 | Lysine Demethylase KDM6A in Differentiation, Development, and Cancer. | 2020 Sep 28 |
1 |
| 10 |
32988590 | Small molecule inhibitors of the prostate cancer target KMT2D. | 2020 Dec 10 |
1 |
| 11 |
33291558 | Epigenetic Role of Histone Lysine Methyltransferase and Demethylase on the Expression of Transcription Factors Associated with the Epithelial-to-Mesenchymal Transition of Lung Adenocarcinoma Metastasis to the Brain. | 2020 Dec 4 |
1 |
| 12 |
30990809 | Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors. | 2019 |
1 |
| 13 |
31587141 | Kabuki syndrome: review of the clinical features, diagnosis and epigenetic mechanisms. | 2019 Dec |
1 |
| 14 |
29404406 | An Mll4/COMPASS-Lsd1 epigenetic axis governs enhancer function and pluripotency transition in embryonic stem cells. | 2018 Jan |
2 |
| 15 |
29440247 | KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis. | 2018 Jan 15 |
1 |
| 16 |
26640146 | ASXL2 promotes proliferation of breast cancer cells by linking ERĪ± to histone methylation. | 2016 Jul 14 |
1 |
| 17 |
26932671 | KMT2D regulates specific programs in heart development via histone H3 lysine 4 di-methylation. | 2016 Mar 1 |
1 |
| 18 |
27055146 | The many layers of epigenetic dysfunction in B-cell lymphomas. | 2016 Jul |
2 |
| 19 |
26032282 | Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene. | 2015 Sep |
3 |
| 20 |
26280580 | RAP1-mediated MEK/ERK pathway defects in Kabuki syndrome. | 2015 Sep |
2 |
| 21 |
25135975 | Regulation of histone H3K4 methylation in brain development and disease. | 2014 Sep 26 |
1 |
| 22 |
24240169 | KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation. | 2013 Nov |
1 |
| 23 |
20433758 | Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon. | 2010 Apr 30 |
1 |
| 24 |
20808952 | MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing. | 2010 Aug 17 |
1 |